← Back to PAHMCJ Volume 2, Issue 1 (January 2025)

Original Article

Author(s): Hasan MJ, Pathan MAS

PAH Med Col J. Jan 2025; 2(1): 3-8

Abstract

Background: Chronic kidney disease (CKD) represents a significant challenge to public health, often accompanied by significant psychological distress, including depression and anxiety. These psychological disorders can negatively influence patients’ quality of life (QoL) and adherence to treatment.

Objective: To determine the prevalence of depression and anxiety in individuals with CKD, examine related risk factors, and assess their effect on QoL.

Methods: A cross-sectional study was carried out at the Department of Nephrology in collaboration with the Department of Psychiatry at Community-Based Medical College, Bangladesh, between January 2023 and December 2024. A total of 83 CKD patients were recruited using purposive sampling, with data collected through validated scales for depression, anxiety, and QoL assessment.

Results: Among 83 CKD patients, depression prevalence was 38.6% and anxiety prevalence was 31.3%. Dialysis dependency (OR: 2.45 for depression, 2.12 for anxiety), low socioeconomic status, and comorbidities were significant risk factors. Depression correlated with reduced physical health (r=-0.52) and emotional well-being (r=-0.61), while anxiety showed similar negative correlations.

Conclusion: Depression and anxiety are common among individuals with CKD and substantially reduce their quality of life. Prompt screening and the incorporation of mental health interventions are crucial for alleviating psychological distress and enhancing patient outcomes.

Keywords

Chronic kidney disease, Depression, Anxiety, Quality of life, Risk factors

📄 Download Full Original Article PDF

How to cite: Hasan MJ, Pathan MAS. Depression and Anxiety in Patients with Chronic Kidney Disease: Prevalence, Risk Factors and Impact on Quality of Life. PAH Med Col J. Jan 2025; 2(1): 3-8.